2024-09-19T07:40:13-05:00 2023-12-31 541149263 YOUNT HYDE & BARBOUR PC PO BOX 2560 WINCHESTER VA 226041760 990 2023-01-01 131772100 NATIONAL PHARMACEUTICAL COUNCIL INC NATI 2028272100 1717 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 20006 JOHN MICHAEL O'BRIEN CEO 2028272100 2024-05-13 1 0 OLIVIA A HUTTON CPA P00964688 5406623417 2024-05-13 2023 2024-08-08 14:25:15Z JOHN MICHAEL O'BRIEN 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 14258507 0 X SEE SCHEDULE O X 1953 NY THE NATIONAL PHARMACEUTICAL COUNCIL (NPC) IS A HEALTH POLICY RESEARCH ORGANIZATION DEDICATED TO THE ADVANCEMENT OF GOOD EVIDENCE AND SCIENCE, AND TO FOSTERING AN ENVIRONMENT IN THE UNITED STATES THAT SUPPORTS MEDICAL INNOVATION. 20 20 15 0 0 0 0 0 9525000 9600000 -1340796 1354697 100439 12 8284643 10954709 0 0 0 0 4250698 4161250 0 0 0 5849214 4939892 10099912 9101142 -1815269 1853567 24620287 23403513 7974230 4783906 16646057 18619607 TO EXPLORE, DEMONSTRATE AND COMMUNICATE - THROUGH RESEARCH, PARTNERSHIP AND EDUCATION - THE ROLE AND VALUE OF INNOVATIVE BIOPHARMACEUTICALS TO ACHIEVE BETTER PATIENT HEALTH. 0 0 NPC FOCUSES ON RESEARCH DEVELOPMENT, INFORMATION DISSEMINATION, EDUCATION AND COMMUNICATION OF THE CRITICAL ISSUES OF EVIDENCE, INNOVATION AND THE VALUE OF MEDICINES FOR PATIENTS. ALL ACTIVITIES UNDERTAKEN BY NPC RELATED TO THESE FUNCTIONS. 0 0 0 1 0 0 0 0 0 1 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 15 0 1 15 1 0 0 0 0 1 1 0 0 0 X 20 20 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X NATIONAL PHARMACEUTICAL COUNCIL 2028272100 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 CHRISTINE MARSH CHAIR 1.00 X X 0 0 0 CHRISTIAN NGUYEN VICE CHAIR AND TREASURER 1.00 X X 0 0 0 JIM CUROTTO DIRECTOR 1.00 X 0 0 0 SHONTELLE DODSON DIRECTOR 1.00 X 0 0 0 CHRIS COMPISI DIRECTOR 1.00 X 0 0 0 EDWARD FEELEY DIRECTOR 1.00 X 0 0 0 CHRIS LEIBMAN DIRECTOR 1.00 X 0 0 0 JAN HANSEN DIRECTOR 1.00 X 0 0 0 REKHA RAMESH DIRECTOR 1.00 X 0 0 0 BETH RADA DIRECTOR 1.00 X 0 0 0 BLASINE PENKOWSKI DIRECTOR 1.00 X 0 0 0 COURTNEY PIRON DIRECTOR 1.00 X 0 0 0 JEREMY ALLEN DIRECTOR 1.00 X 0 0 0 PHIL NAUGHTON DIRECTOR 1.00 X 0 0 0 PATTY FRITZ DIRECTOR 1.00 X 0 0 0 JOHN O'BRIEN PRESIDENT, CEO 40.00 X X 1462383 0 35532 KIMBERLY WESTRICH CHIEF STRATEGY OFFICER 40.00 X X 74038 0 0 RICK DUDEK DIRECTOR 1.00 X 0 0 0 RUTH HOFFMAN DIRECTOR 1.00 X 0 0 0 CHRIS MANCILL DIRECTOR 1.00 X 0 0 0 TRENT MCLAUGHLIN DIRECTOR 1.00 X 0 0 0 MOHIT MANRAO DIRECTOR 1.00 X 0 0 0 ROBERT NORDYKE VICE PRESIDENT OF RESEARCH 40.00 X 289469 0 14499 JONATHON CAMPBELL CHIEF SCIENCE OFFICER 40.00 X 237568 0 19510 MICHAEL PRATT CHIEF COMMUNICATIONS OFFICER 40.00 X 225666 0 16644 ROCHELLE HENDERSON VICE PRESIDENT OF RESEARCH 40.00 X 241996 0 24136 TANYA BAILEY HEAD OF MEMBERSHIP AND MEETINGS 40.00 X 131901 0 25294 NICOLE BERRY DIRECTOR OF ADMINISTRATION 40.00 X 128580 0 30811 JAMES D MOTYKA RESEARCH ASSOCIATE 40.00 X 129894 0 12089 JULIE PATTERSON SENIOR DIRECTOR OF RESEARCH 40.00 X 197246 0 34472 3118741 0 212987 10 0 1 0 REAL CHEMISTRY PO BOX 23718 NEW YORK NY 10087 RESEARCH AND COMMUNICATIONS 753989 PROJECT HOPE 1220 19TH STREET NW SUITE 800 WASHINGTON DC 20001 RESEARCH 735000 TUFTS MEDICAL CENTER 800 WASHINGTON ST BOX 453 BOSTON MA 02111 RESEARCH 641178 IQVIA INC PO BOX 8500-784290 PHILADELPHIA PA 191784290 RESEARCH 528550 DISCERN LLC 100 CAMPUS DRIVE SUITE 300 FLORHAM PARK NJ 07932 RESEARCH 283765 10 MEMBERSHIP DUES 900099 9600000 9600000 9600000 588056 588056 4070439 3303798 766641 766641 766641 OTHER INCOME 900099 12 12 12 10954709 9600012 0 1354697 2289122 998797 343208 257914 272209 114551 77500 52296 88652 31947 147745 319531 165389 159648 2021 80210 33770 EXPENDITURES FOR PROJEC 3528664 MISCELLANEOUS 73570 SUBSCRIPTIONS & DUES 64398 9101142 10957786 8336692 131120 268568 68326 62374 206877 986426 615890 401180 268736 214710 10741314 11578325 2246128 1956418 24620287 23403513 1014472 653303 3750000 1150000 3209758 2980603 7974230 4783906 X 16646057 18619607 16646057 18619607 24620287 23403513 1853567 119983 0 X X 0 1 X 1 0 1 1 0 199688 75715 123973 232629 188763 43866 183573 136702 46871 214710 SECURITY DEPOSITS 26198 LEASE RIGHT OF USE ASSETS 1930220 1956418 NONQUALIFIED, DEFERRED COMPENSATION LIABILITY 484310 LEASE LIABILITIES - NON-CURRENT 2496293 2980603 11022396 119983 119983 10902413 52296 52296 10954709 9048846 0 9048846 52296 52296 9101142 1 X X X 0 0 0 JOHN O'BRIEN PRESIDENT, CEO 789375 0 409773 0 263235 0 16500 0 19032 0 1497915 0 0 0 ROBERT NORDYKE VICE PRESIDENT OF RESEARCH 257500 0 30900 0 1069 0 12875 0 1624 0 303968 0 0 0 ROCHELLE HENDERSON VICE PRESIDENT OF RESEARCH 241654 0 0 0 342 0 11802 0 12334 0 266132 0 0 0 JONATHON CAMPBELL CHIEF SCIENCE OFFICER 201335 0 36132 0 101 0 6875 0 12635 0 257078 0 0 0 MICHAEL PRATT CHIEF COMMUNICATIONS OFFICER 200664 0 24948 0 54 0 6042 0 10602 0 242310 0 0 0 JULIE PATTERSON SENIOR DIRECTOR OF RESEARCH 169850 0 27250 0 146 0 8750 0 25722 0 231718 0 0 0 NICOLE BERRY DIRECTOR OF ADMINISTRATION 113220 0 14640 0 720 0 6100 0 24711 0 159391 0 0 0 TANYA BAILEY HEAD OF MEMBERSHIP AND MEETINGS 112750 0 18000 0 1151 0 6000 0 19294 0 157195 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE TREASURER AND THE CHIEF OPERATING OFFICER PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY COVERS ALL MEMBERS OF THE BOARD, THE OFFICERS, AND STAFF AND IS MONITORED BY ANNUAL WRITTEN INFORMATION QUESTIONNAIRES FROM THE COO AND SENIOR VP WHICH ARE REVIEWED AND MAINTAINED BY THE COO AND SENIOR VP. THE BOARD OFFICERS REVIEW EACH ISSUE TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF ANY POTENTIAL OR ACTUAL CONFLICTS ARE IDENTIFIED THE PERSON DETERMINED TO HAVE A CONFLICT IS RECUSED FROM DELIBERATIONS, VOTING OR ANY ACTIONS RELATED TO THE MATTER. THE IDENTIFIED CONFLICTS WOULD BE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING IF AN OFFICAL VOTE WAS TAKEN. FORM 990, PART VI, SECTION B, LINE 15 THE CHAIRMAN OF THE BOARD REVIEWS AND APPROVES THE SALARY FOR THE PRESIDENT. THE PRESIDENT AND CEO REVIEWS AND APPROVES ALL OTHERS WITHIN THE BUDGET. ALL SALARIES WERE APPROVED IN 2023. FORM 990, PART VI, SECTION C, LINE 19 THE NATIONAL PHARMACEUTICAL COUNCIL DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART XII, LINE 2C: PROCESS HAS NOT CHANGED